Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person4
HAEMONETICS CORP
Company
Horizon Kinetics Holding Corp
Company
Ionetix Corp / DE /
Company
HNI CORP
Company
Primary record6
HAEMONETICS CORP filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 5, 2026, Haemonetics Corporation issued a press release announcing financial results for the second quarter ended September 26, 2026 and first half of
HAEMONETICS CORP filed 4
SEC form 4 filed by HAEMONETICS CORP (CIK 313143) on 2026-11-03.
HAEMONETICS CORP filed 8-K
Item 7.01 Regulation FD Disclosure On August 18, 2026, Haemonetics Corporation (the Company ) furnished a Current Report on Form 8-K disclosing its entry into a non-exclusive supply agreement with CSL Plasma Inc. ( CSL )
Azenta, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of President and Chief Executive Officer On August
HAEMONETICS CORP filed 8-K
Item 7.01 Regulation FD Disclosure On August 14, 2026, Haemonetics Corporation (the Company ) entered into a supply agreement with CSL Plasma Inc. ( CSL ) pursuant to which CSL may utilize the Company s NexSys PCS device
AQR CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A
0001167557-26-000152.txt : 20260812 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001167557-26-000036 0001167557 XXXXXXXX LIVE 1 Common stock, $0.01 par value per share 06/30/2026 0000313143 HAEMONETICS CORP 405